The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $118.45

Today's change0.00 0.00%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $118.45

Today's change0.00 0.00%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

United Therapeutics Corp closed at (U.S.)$118.45.

Over the last five days, shares have lost 3.84% and sit 1.59% above their 52-week low. This security has underperformed the S&P 500 by 7.69% during the last year.

Key company metrics

  • Open(U.S.) $121.20
  • Previous close(U.S.) $118.45
  • High(U.S.) $122.55
  • Low(U.S.) $116.60
  • Bid / Ask-- / --
  • YTD % change-24.37%
  • Volume1,186,284
  • Average volume (10-day)807,541
  • Average volume (1-month)719,941
  • Average volume (3-month)731,029
  • 52-week range(U.S.) $116.60 to (U.S.) $190.29
  • Beta1.72
  • Trailing P/E9.14×
  • P/E 1 year forward8.93×
  • Forward PEG0.41×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $12.96
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.08%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue386347328346
Total other revenue--------
Total revenue386347328346
Gross profit379331307331
Total cost of revenue7162116
Total operating expense-1175342168
Selling / general / administrative-1711021181
Research & development104911071
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income387172-15179
Interest income (expense), net non-operating-1-1-2-4
Gain (loss) on sale of assets350------
Other--------
Income before tax737168-17175
Income after tax46499-17116
Income tax, total27269059
Net income46499-17116
Total adjustments to net income--------
Net income before extra. items46499-17116
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items46499-17116
Inc. avail. to common incl. extra. items46499-17116
Diluted net income46499-17116
Dilution adjustment--------
Diluted weighted average shares50524754
Diluted EPS excluding extraordinary itemsvalue per share9.241.91-0.362.17
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share4.851.91-0.362.17